Invention Grant
US08404680B2 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors 有权
作为BACE1和/或BACE2抑制剂的N- [3-(5-氨基-3,3a,7,7a-四氢-1H-2,4-二氧杂-6-氮杂 - 茚-7-基) - 苯基]酰胺

  • Patent Title: N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors
  • Patent Title (中): 作为BACE1和/或BACE2抑制剂的N- [3-(5-氨基-3,3a,7,7a-四氢-1H-2,4-二氧杂-6-氮杂 - 茚-7-基) - 苯基]酰胺
  • Application No.: US13364672
    Application Date: 2012-02-02
  • Publication No.: US08404680B2
    Publication Date: 2013-03-26
  • Inventor: Hans HilpertRoland Humm
  • Applicant: Hans HilpertRoland Humm
  • Applicant Address: US NJ Nutley
  • Assignee: Hoffmann-La Roche Inc.
  • Current Assignee: Hoffmann-La Roche Inc.
  • Current Assignee Address: US NJ Nutley
  • Agent George W. Johnston; Patricia S. Rocha-Tramaloni; Kimberly J. Prior
  • Priority: EP11153633 20110208
  • Main IPC: C07D498/04
  • IPC: C07D498/04 A61K31/5365
N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors
Abstract:
The present invention relates to N-[3-(5-Amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides of formula I having BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.
Information query
Patent Agency Ranking
0/0